Skip to main content
SpringerLink
Log in

Urologika

  • Chapter
Arzneiverordnungs-Report 2002

  • 52 Accesses

Zusammenfassung

Hauptgruppe der Urologika sind die Prostatamittel mit über 75% der Verordnungen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abrams P., Freeman R., Anderström C., Mattiasson A. (1998): Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br. J. Urol. 81: 801 – 810.

    Article  CAS  PubMed  Google Scholar 

  • Berges R.R., Windeler H., Trampisch H.J., Senge T. and the ß-sitosterol study group (1995): Randomised, placebo-controlled, double-blind clinical trial of 1-sitosterol in patients with benign prostatic hyperplasia. Lancet 345: 1529 – 1532.

    Article  Google Scholar 

  • Bergogne-Berezin E., Berthelot G., Muller-Serieys C. (1987): Present status of nitroxoline. Pathol. Biol. (Paris) 35: 873 – 878.

    CAS  Google Scholar 

  • Bhatia N.N., Karram M.M., Bergman A., Evans R.P. (1992): Antibiotic prophylaxis following lower urinary tract instrumentation. Urology 39: 583 – 585.

    Article  CAS  PubMed  Google Scholar 

  • Boyle P., Gould A.L., Roehrborn C.G. (1996): Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. Urology 48: 398 – 405.

    Article  CAS  PubMed  Google Scholar 

  • Bundesgesundheitsamt (1994): Aufbereitungsmonographie Uvae ursi folium (Bärentraubenblätter). Bundesanzeiger Nr. 109, S. 6213, 15. 6. 1994.

    Google Scholar 

  • Burgio K.L., Locher J.L., Goode P.S., Hardin J.M., McDowell B.J. et al. (1998): Behavioral vs. drug treatment for urge urinary incontinence in older women. A randomized controlled trial. JAMA 280: 1995 – 2000.

    Article  CAS  PubMed  Google Scholar 

  • Buzelin J.M., Fonteyne E., Kontturi M. Witjes W.P., Khan A. (1997) Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign pro-static hyperplasia). The European Tamsulosin Study Group. Br. J. Urol. 80: 597 – 605

    Article  CAS  PubMed  Google Scholar 

  • Caine M., Raz S., Ziegler M. (1975): Adrenergic and cholinergic receptors in the human prostate., prostatic capsule, and bladder neck. Brit. J. Urol. 27: 193202.

    Google Scholar 

  • Chapple C.R. (1996): Selective a,-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. Eur. Urol. 29: 129 – 144.

    CAS  PubMed  Google Scholar 

  • Chapple C.R. (2000): Muscarinic receptor antagonists in the treatment of overactive bladder. Urology 55 (5A Suppl.): 33 – 46.

    Article  CAS  PubMed  Google Scholar 

  • Cobb M.M., Salen G., Tint G.S. (1997): Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject. J. Am. Coll. Nutr. 16: 605 – 613.

    CAS  PubMed  Google Scholar 

  • Coraggio M.J., Gross T.P., Roscelli J.D. (1989): Nitrofurantoin toxicity in children. Pediatr. Infect. Dis. J. 8: 163 – 166.

    CAS  PubMed  Google Scholar 

  • Cundiff, G.W., McLennan M.T., Bent A.E. (1999): Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. Obstet. Gynecol. 93 (5 Pt. 1): 749 – 752.

    Article  CAS  PubMed  Google Scholar 

  • Dreikorn K. (2002) The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. World J. Urol. 19: 426 – 435

    Google Scholar 

  • de Mey C., Michel M.C., McEwen J., Moreland T. (1998) A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur. Urol. 33: 481 – 488.

    Article  PubMed  Google Scholar 

  • Drutz H.P., Appell R.A., Gleason D., Klimberg I., Radomski S. (1999): Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int. Urogynecol. J. 10: 283 – 289.

    Article  CAS  Google Scholar 

  • Editorial (1988): Medical treatment of benign prostatic hyperplasia. Lancet I: 1083 – 1084.

    Google Scholar 

  • Expertengruppe and Arbeitskreis BPH (1999): Leitlinien der Deutschen Urologen zur Therapie des BPH-Syndroms. Urologe (A) 38: 529 – 536.

    Article  Google Scholar 

  • Flanigan R.C., Reda D.J., Wasson J.H., Anderson R.J., Abdellatif M., Bruskewitz R.C. (1998): 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J. Urol. 160: 12 – 16.

    Google Scholar 

  • Foglar R., Shibata K., Horie K., Hirasawa A., Tsujimoto G. (1995): Use of recombinant a1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur. J. Pharmacol. 288: 201 – 207.

    Article  CAS  PubMed  Google Scholar 

  • Goepel M., Hecker U., Krege S., Rubben H., Michel M.C. (1999): Saw palmetto extracts potently and noncompetitively inhibit human alpha,-adrenoceptors in vitro. Prostate 38: 208 – 215.

    Article  CAS  PubMed  Google Scholar 

  • Grasso M., Montesano A., Buonaguidi A., Castelli M., Lania C. et al. (1995): Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia. Arch. Esp. Urol. 48: 97 – 103.

    CAS  PubMed  Google Scholar 

  • Guay D.R.P. (1999): Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity. Pharmacotherapy 19: 267 – 280.

    Article  CAS  PubMed  Google Scholar 

  • Hadorn D.C., Baker D., Hodges J.S., Hicks N. (1996): Rating the quality of evidence for clinical practice guidelines. J Clin. Epidemiol. 49: 749 – 754.

    Article  CAS  PubMed  Google Scholar 

  • Harvey M.-A., Baker K., Wells G.A. (2001): Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: A meta-analysis. Am. J. Obstet. Gynecol. 185: 56 – 61.

    Article  CAS  PubMed  Google Scholar 

  • Hay-Smith E.J., Bo Berghmans L.C., Hendriks H.J., de Bie R.A. van Waalwijk van Doorn E.S. (2001): Pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst. Rev. 2001 (1): CD001407.

    Google Scholar 

  • Hooton T.M., Winter C., Tiu F., Stamm W.E. (1995): Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 273: 41 – 45.

    Article  CAS  PubMed  Google Scholar 

  • Iselin C.E., Schmidlin F., Borst E, Rohner S., Graber P. (1997): Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate. Brit. J. Urol. 79: 915 – 919.

    Article  CAS  PubMed  Google Scholar 

  • Janssen C.C.M., Lagro-Janssen A.L.M., Felling A.J.A. (2001): The effects of physiotherapy for female urinary incontinence: individual compared with group treatment. Brit. J. Urol. Int. 87: 201 – 206.

    Article  CAS  Google Scholar 

  • Johnson H.W., Anderson J.D., Chambers G.K., Arnold W.J., Irwin B.J., Brinton J.R. (1994): A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. Pediatrics 93: 752755.

    Google Scholar 

  • Klippel K.F., Hiltl D.M., Schipp B. (1997): A multicentric, placebo-controlled, double-blind clinical trial of ß-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Brit. J. Urol. 80: 427 – 432.

    Article  CAS  PubMed  Google Scholar 

  • Larsson G., Hallén B., Nilvebrant L. (1999): Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data. Urology 53: 990998.

    Google Scholar 

  • Lepor H., Williford W.O., Barry M.J., Brawer M.K., Dixon C.M. et al. (1996): The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N. Engl. J. Med. 335: 533 – 539.

    Article  CAS  PubMed  Google Scholar 

  • Malinverni R., Hoigné R., Sonntag R. (1996): Sulfonamides, other folic acid antagonists and miscellaneous antibacterial drugs. In: Dukes M.N.G. (ed.): Meyler’s side effects of drugs. 13th ed. Elsevier, Amsterdam Lausanne New York Oxford Shannon Tokyo, pp. 843 – 871.

    Google Scholar 

  • Malone-Lee J.G., Walsh J. B., Maugourd M.-F. and the Tolterodine in the Elderly Study Group (2001): Tolterodine: A safe and effective treatment for older patients with overactive bladder. J. Am. Geriatr. Soc. 49: 700 – 705.

    Article  Google Scholar 

  • McDowell B.J., Engberg S., Sereika S., Donovan N., Jubeck M.E., Weber E., Engberg R. (1999): Effectiveness of behavioral therapy to treat incontinence in homebound older adults. J. Am. Geriatr. Soc. 47: 309 – 318.

    CAS  PubMed  Google Scholar 

  • Millard R., Tuttle J., Moore K., Susset J.,Clarke B., Dwyer P., Davis B.E. (1999): Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J. Urol. 161: 1551 – 1555.

    Article  CAS  PubMed  Google Scholar 

  • Moore K.H., Hay D.M., Imrie A.F.., Watson A., Goldstein M. (1990): Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Brit. J. Urol. 66: 479 – 485.

    Article  CAS  PubMed  Google Scholar 

  • Ouslander J.G., Blaustein J., Connor A., Pitt A. (1988): Habit training and oxybutynin for incontinence in nursing home patients: a placebo-controlled trial. J. Am. Geriatr. Soc. 36: 40 – 46.

    CAS  PubMed  Google Scholar 

  • Ouslander J.G., Schnelle J.F., Uman G., Fingold S., Nigam J.G. et al. (1995): Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial. J. Am. Geriatr. Soc. 43: 610 – 617.

    CAS  PubMed  Google Scholar 

  • Rentzhog L., Stanton S.L., Clardozo L., Nelson E., Fall M., Abrams P. (1998): Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. Br. J. Urol. 81: 42 – 48.

    Article  CAS  PubMed  Google Scholar 

  • Riva D., Casolati E. (1984): Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment. Clin. Exp. Obst. Gyn. 11: 37 – 42.

    CAS  Google Scholar 

  • Roe B., Williams K., Palmer M. (2002): Bladder training for uninary incontinence in adults (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.

    Google Scholar 

  • Schlager T.A., Anderson S., Trudell J., Hendley J.O. (1998): Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J. Pediatr. 132: 704708.

    Google Scholar 

  • Simon C., Stille W. (2000): Antibiotika-Therapie in Klinik und Praxis. 10. Aufl., Schattauer, Stuttgart New York, S. 238 – 241, 247–252.

    Google Scholar 

  • Snyder R., Witz G., Goldstein B.D. (1993): The toxicology of benzene. Environ. Health Perspect. 100: 293 – 306.

    Article  CAS  PubMed  Google Scholar 

  • Stamm W.E., Counts G.W., Wagner K.F., Martin D., Gregory D. et al. (1980): Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann. Intern. Med. 92: 770 – 775.

    Article  CAS  PubMed  Google Scholar 

  • Stöhrer M., Bauer P., Giannetti B.M., Richter R., Burgdörfer H., Wirtz G. (1991): Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. Urol. Int. 47: 138 – 143.

    Article  PubMed  Google Scholar 

  • Subak L.L., Quesenberry C.P., Posner S.F., Cattolica E., Soghikian K. (2002): The effect of behavioral therapy on urinary incontinence: a randomized controlled trial. Obstet. Gynecol. 100; 72 – 78.

    Article  PubMed  Google Scholar 

  • Szonyi G., Collas D.M., Ding Y.Y., Malone-Lee J.G. (1995): Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial. Age Ageing 24: 287 – 291.

    Article  CAS  PubMed  Google Scholar 

  • Tapp A.J.S., Cardozo L.D., Versi E., Cooper D. (1990): The treatment of detrusor instability in postmenopausal women with oxyxbutynin chloride: a double blind placebo controlled study. Brit. J. Obstet. Gynaec. 97: 521 – 526.

    Article  CAS  PubMed  Google Scholar 

  • Thüroff J.W., Bunke B., Ebner A., Faber P., de Geeter P. et al. (1991): Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J. Urol. 145: 813 – 817.

    PubMed  Google Scholar 

  • Thüroff J.W., Chartier-Kastler E., Corcus J., Humke J., Jonas U. et al. (1998): Medical treatment and medical side effects in urinary incontinence in the elderly. World J. Urol. 16 (suppl): S48 – S61.

    Google Scholar 

  • Uhari M., Nuutinen M., Turtinen J. (1996): Adverse reactions in children during long-term antimicrobial therapy. Pediatr. Infect. Dis. 15: 404 – 418.

    Article  CAS  Google Scholar 

  • Van Kerrebroeck P.E.V.A., Amarenco G,. Thüroff J.W., Madersbacher H.G., Lock M.T.W.T., Messelink E.J., Soler J.M. (1998): Dose-ranging study of tolterodine in patients with detrusor hyperreflexia. Neurourol. Urodynam. 17: 499 – 512.

    Article  Google Scholar 

  • Van Kerrebroeck P.E.V.A., Kreder K., Jonas U., Zinner N., Wein A. for the Tolterodine Study Group (2001): Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57: 414 – 421.

    Article  PubMed  Google Scholar 

  • Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. for the Infectious Diseases Society of America (IDSA) (1999): Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29: 745 – 758.

    Article  CAS  PubMed  Google Scholar 

  • Wehnert J., Sage S. (1992): Therapie der Blaseninstabilität and Urge-Inkontinenz mit Propiverin hydrochlorid (Mictonorm®) and Oxybutyninchlorid (Dridase®) – eine randomisierte Cross-over-Vergleichsstudie. Akt. Urol. 23: 7 – 11.

    Article  Google Scholar 

  • Wyman J.F., Fantl J.A., McClish D.K., Bump R.C. (1998): Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. Am. J. Obstet Gyneco1. 179: 999 – 1007.

    Article  CAS  Google Scholar 

  • Zinner N.R., Mattiasson A., Stanton S.L. (2002): Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J. Am. Geriatr. Soc. 50: 799 – 807.

    Article  PubMed  Google Scholar 

  • Zorzitto M.L., Holliday P.J., Jewett M.A.S., Herschorn S., Fernie G.R. (1989): Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study. Age Ageing 18: 195 – 200.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Bernd Mühlbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hartmut Osswald
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Deutschland

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln, Deutschland

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mühlbauer, B., Osswald, H. (2003). Urologika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2002. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11173-4_47

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-11173-4_47

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-43624-9

  • Online ISBN: 978-3-662-11173-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation